解剖病理学市场规模（按产品/服务、应用、最终用户、地区、范围和预测）

解剖病理学市场规模及预测

2024 年解剖病理学市场规模价值为 205.4 亿美元，预计到 2031 年将达到 319.2 亿美元，预测期内（2024-2031 年）的复合年增长率为 5.67%。

解剖病理学是病理学的一个分支，透过检查器官和组织来诊断疾病。

该领域的基础是视觉检查，涉及仔细评估组织的宏观特征、大小、形状、颜色和一致性。

然后仔细处理样品并准备进行显微分析。薄切片用特殊染料染色以突出细胞和结构细节。

病理学家，经过有关疾病过程和组织形态学的广泛培训的医生，在显微镜下观察这些切片。病理学家仔细评估微观特征，寻找可能解释潜在疾病的特征性异常。

解剖病理学市场动态

影响解剖病理学市场的关键市场动态

主要市场驱动因子

增加疾病负担：

疾病负担加重：慢性病尤其是癌症发生率的增加是一个主要推动因素。解剖病理学在诊断这些疾病中起着关键作用，促使对相关服务和产品的需求增加。

越来越重视个人化医疗：

个人化医疗涉及根据个人的基因和分子组成製定治疗计划。解剖病理学在透过先进技术识别这些目标方面发挥关键作用，从而推动了市场成长。

技术进步：

数位病理学的出现正在改变这个领域。数位化允许对幻灯片进行远端分析，提高工作流程效率并促进病理学家之间的合作。此外，免疫组织化学和分子检测的进步正在提高诊断的准确性，进一步支持市场扩张。

增加政府资助和报销措施：

政府对医疗保健基础设施的支持不断增加，以及促进疾病早期发现的举措，促进了市场的成长。鼓励使用先进诊断技术的报销政策也发挥着重要作用。

主要问题

严格的监理要求：

新的诊断测试和设备的开发和批准需要严格的监管监督。这既费时又昂贵，阻碍了新技术快速转化为临床实践。

缺乏人力：

全球疾病负担不断加重，加上合格病理学家数量有限，给解剖病理学部门带来了压力。工作人员短缺导致诊断延迟并降低整个医疗保健系统的效率。

整合成本与资料安全问题：

引入数位病理学等尖端技术需要大量的基础设施投资。此外，需要有效解决与数位病理学工作流程相关的资料安全和隐私问题。

赎回压力：

医疗保健付款人不断寻求成本控制。先进的诊断测试可以改善患者的治疗效果，但获得这些测试的足够报销可能具有课题性，从而限制了它们在某些情况下的可用性。

主要趋势：

数位病理学应用的激增：

数位病理学工作流程的采用正在加速。该技术促进了远端幻灯片分析，使地理位置分散的病理学家能够协作并提高工作流程效率。数位幻灯片可以轻鬆储存和共享，从而改善沟通和案例讨论。

进阶诊断整合：

解剖病理学越来越多地融入免疫组织化学和分子生物学测试等先进的诊断技术。这些进步将提高疾病诊断的准确性，从而实现更有针对性的治疗方法并改善患者的治疗效果。这一趋势是由个人化医疗日益增长的兴趣所推动的。

工作流程最佳化：

解剖病理学实验室正在努力简化其工作流程。这包括自动化日常任务、改进设备和软体整合以及采用数位病理学解决方案。这些进步旨在提高效率并减少诊断所需的时间。

新兴市场具有成长潜力：

中国和印度等新兴经济体为解剖病理学市场提供了巨大的成长机会。这是由于医疗成本上升、人们对慢性病的认识增强以及医疗基础设施投资增加等因素所造成的。

解剖病理学市场区域分析

北美：

北美目前在全球解剖病理学市场中占据主导地位，预计在可预见的未来将继续保持领先地位。

该地区是主要解剖病理学公司的所在地，并拥有完善的医疗保健体系。

北美的政府机构正在积极支持病理学家培训计划和早期疾病检测计划。

北美的医院和临床实验室通常拥有先进的技术和基础设施。这种强大的基础设施将促进新的诊断工具和技术的无缝整合。

北美慢性病（尤其是癌症）发生率的不断增加，推动了对解剖病理学服务的需求。

亚太地区：

亚太地区 (APAC) 是解剖病理学的一个不断增长的市场，并显示出巨大的成长潜力。

与全球趋势一致，亚太地区慢性病，尤其是癌症的发生率正在上升。这使得诊断程序的数量激增，从而推动了对解剖病理学服务和产品的需求。

许多亚太国家人口老化迅速，增加了罹患慢性病的风险，也进一步增加了对先进诊断工具的需求。

亚太地区各国政府正在加大对医疗保健基础设施的投资。这包括建立配备最新技术的新医院和实验室，促进采用先进的解剖病理学技术。

许多亚太地区国家的可支配收入不断增加，促使医疗保健支出增加。这种在医疗保健上花费的意愿正在推动解剖病理学服务和技术市场的发展。

目录

第 1 章全球解剖病理学市场：简介

市场概况
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第 4 章全球解剖病理学市场展望

• 概述
• 市场动态
  • 驱动程式
  • 阻碍因素
  • 机会
• 波特五力模型
• 价值链分析

第5章 全球解剖病理学市场（按产品和服务划分）

• 概述
• 装置
• 消耗品
• 服务

第6章 全球解剖病理学市场（按应用）

• 概述
• 疾病诊断
• 药物发现与开发
• 其他

第7章 全球解剖病理学市场（按最终用户划分）

• 概述
• 医院
• 诊断实验室
• 研究实验室
• 其他

第8章 全球解剖病理学市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
  亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第 9 章全球解剖病理学市场的竞争格局

• 概述
• 各公司的市场排名
• 主要发展策略

第10章 公司简介

• Thermo Fisher Scientific
• Agilent Technologies
• F. Hoffmann-La Roche Ltd.
• Sakura Finetek
• Danaher Corporation
• Hologic, Inc.
• Merck KGaA
• Bio SB
• Becton, Dickinson and Company
• Diapath S.p.A.

第 11 章附录

• 相关研究

Anatomic Pathology Market Size And Forecast

Anatomic Pathology Market size was valued at USD 20.54 Billion in the year 2024, and it is expected to reachUSD 31.92 Billion in 2031, at aCAGR of 5.67% over the forecast period of 2024 to 2031.

Anatomic pathology is a subspecialty of pathology concerned with diagnosing disease through examining organs and tissues.

The field's foundation lies in meticulous gross examination, where the tissue's macroscopic features, size, shape, color, and consistency are meticulously evaluated.

Subsequently, samples are carefully processed and prepared for microscopic analysis. Thin sections are stained with specialized dyes to highlight cellular and structural details.

A pathologist, a physician with extensive training in disease processes and tissue morphology, examines these sections under a microscope. The pathologist meticulously evaluates the microscopic features, searching for characteristic abnormalities that can explain the underlying disease.

Anatomic Pathology Market Dynamics

The key market dynamics that are shaping the anatomic pathology market include:

Key Market Drivers

Rising Burden of Disease:

The increasing incidence of chronic diseases, particularly cancer, is a major driver. Anatomic pathology plays a vital role in diagnosing these conditions, leading to a rising demand for associated services and products.

Growing Focus on Personalized Medicine:

Personalized medicine tailors treatment plans to an individual's specific genetic and molecular makeup. Anatomic pathology plays a crucial role in identifying these targets through advanced techniques, propelling the market growth.

Technological Advancements:

The emergence of digital pathology is transforming the field. Digitalization allows for remote analysis of slides, improves workflow efficiency, and facilitates collaboration among pathologists. Additionally, advancements in immunohistochemistry and molecular testing are enhancing diagnostic accuracy, further driving market expansion.

Increased Government Funding and Reimbursement Initiatives:

Growing government support for healthcare infrastructure and initiatives promoting early disease detection are contributing to market growth. Reimbursement policies that incentivize the use of advanced diagnostic techniques are also playing a significant role.

Key Challenges:

Stringent Regulatory Requirements:

The development and approval of new diagnostic tests and equipment are subject to rigorous regulatory oversight. This can be a lengthy and expensive process, hindering the swift integration of novel technologies into clinical practice.

Workforce Shortages:

A growing global burden of disease coupled with a limited number of qualified pathologists creates a strain on anatomic pathology departments. This shortage can lead to delays in diagnoses and hinder the overall efficiency of the healthcare system.

Integration Costs and Data Security Concerns:

The adoption of advanced technologies like digital pathology necessitates significant infrastructure investments. Additionally, concerns regarding data security and privacy associated with digital pathology workflows need to be addressed effectively.

Reimbursement Pressures:

Healthcare payors are constantly seeking to control costs. While advanced diagnostic tests can improve patient outcomes, obtaining adequate reimbursement for these tests can be challenging, limiting their accessibility in certain settings.

Key Trends:

Surge in Digital Pathology Adoption:

Digital pathology workflows are being increasingly embraced. This technology facilitates remote slide analysis, enabling collaboration among geographically dispersed pathologists and improving workflow efficiency. The ability to store and share digital slides effortlessly fosters improved communication and case consultations.

Integration of Advanced Diagnostics:

Anatomic pathology is witnessing the integration of advanced diagnostic techniques like immunohistochemistry and molecular testing. These advancements offer greater precision in disease diagnosis, allowing for more targeted treatment approaches and improved patient outcomes. This trend is being driven by the growing focus on personalized medicine.

Focus on Workflow Optimization:

Efforts are being directed towards streamlining workflows in anatomic pathology laboratories. This includes automating routine tasks, improving the integration of instruments and software, and adopting digital pathology solutions. These advancements aim to enhance efficiency and reduce turnaround times for diagnoses.

Emerging Markets Offer Growth Potential:

Developing economies like China and India present significant growth opportunities for the anatomic pathology market. This is due to factors such as rising healthcare expenditure, increasing awareness of chronic diseases, and growing investments in healthcare infrastructure.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Anatomic Pathology Market Regional Analysis

Here is a more detailed regional analysis of the anatomic pathology market:

North America:

North America currently holds the dominant position in the global anatomic pathology market, and its leadership is expected to continue for the foreseeable future.

The region boasts a well-established healthcare system with a concentration of leading companies in the anatomic pathology space.

Government agencies in North America actively support initiatives related to pathologist training programs and early disease detection programs.

Hospitals and clinical laboratories in North America are generally well-equipped with advanced technology and infrastructure. This robust infrastructure facilitates the seamless integration of novel diagnostic tools and techniques.

The growing incidence of chronic diseases, particularly cancer, in North America fuels the demand for anatomic pathology services.

Asia Pacific:

The Asia Pacific (APAC) region represents a growing market for anatomic pathology, exhibiting significant growth potential.

Similar to global trends, APAC experiences a growing prevalence of chronic diseases, particularly cancer. This necessitates a surge in diagnostic procedures, driving demand for anatomic pathology services and products.

Rapid population aging in many APAC countries translates into a higher risk of chronic diseases, further amplifying the need for advanced diagnostic tools.

Governments across APAC are increasingly investing in healthcare infrastructure development. This includes the establishment of new hospitals and laboratories equipped with modern technology, fostering the adoption of advanced anatomic pathology techniques.

Disposable incomes are rising in many APAC countries, leading to increased healthcare expenditure. This willingness to spend on healthcare fuels the market for anatomic pathology services and technologies.

Anatomic Pathology Market Segmentation Analysis

The Anatomic Pathology Market is segmented based on Product And Service, Application, End-User, And Geography.

Anatomic Pathology Market, By Product And Service

• Instruments
• Consumables
• Services

Based on Product & Service, the market is divided into instruments, consumables, and services. The service segment dominates the market with the largest market share in 2019 and is expected to register the highest CAGR during the forecast period. This dominance is attributed to factors such as the availability of reimbursement for diagnostic tests, rapid growth in the geriatric population, and increasing incidence of cancer and other chronic diseases.

Anatomic Pathology Market, By Application

• Disease Diagnosis
• Drug Discovery And Development
• Others

Based on Application, the market is segmented into disease diagnosis, drug discovery and development, and others. In 2019, the disease diagnosis segment held the largest market share. This growth can be attributed to the rapid increase in the geriatric population and the rising incidence of cancer and other chronic diseases.

Anatomic Pathology Market, By End-User

• Hospitals
• Diagnostic Laboratories
• Research Laboratories
• Others

Based on end-user, the market is segmented into hospitals, diagnostic laboratories, research laboratories, and others. Diagnostic laboratories, followed by hospitals, have been dominating the market in terms of market share.

Anatomic Pathology Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of The World

Based on Geography, the anatomic pathology market is classified into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. The major factors driving the growth in the Anatomic Pathology Market in these regions include easy access to advanced technologies, government initiatives for cancer patient screening, favorable reimbursement scenarios for Anatomic Pathology Diagnostic Tests, increased healthcare expenditure, and the presence of high-quality infrastructure in hospitals and clinical laboratories.

Key Players

• The "Anatomic Pathology Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
• Thermo Fisher Scientific, Agilent Technologies, F. Hoffmann-La Roche Ltd., Sakura Finetek, Danaher Corporation, Hologic, Inc., Merck KGaA, Bio SB, Becton, Dickinson and Company, and Diapath S.p.A.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Anatomic Pathology Market Key Developments

• In September 2022, Epredia's parent company, PHC Holdings Corporation, strategically expanded its presence in Europe by acquiring anatomical pathology suppliers Microm Microtech France and Laurypath.
• In July 2022, BillionToOne, a United States-based company, launched its first oncology liquid biopsy products, Northstar Select and Northstar Response.
• In June 2022, Roche introduced the VENTANA DP 600 slide scanner, designed for digital pathology. This innovative technology is employed in anatomic pathology and bolsters patient care through precise diagnostics.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ANATOMIC PATHOLOGY MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ANATOMIC PATHOLOGY MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ANATOMIC PATHOLOGY MARKET, BY PRODUCT AND SERVICE

• 5.1 Overview
• 5.2 Instruments
• 5.3 Consumables
• 5.4 Services

6 GLOBAL ANATOMIC PATHOLOGY MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Disease Diagnosis
• 6.3 Drug Discovery and Development
• 6.4 Others

7 GLOBAL ANATOMIC PATHOLOGY MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Diagnostic Laboratories
• 7.4 Research Laboratories
• 7.5 Others

8 GLOBAL ANATOMIC PATHOLOGY MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL ANATOMIC PATHOLOGY MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Thermo Fisher Scientific
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Agilent Technologies
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 F. Hoffmann-La Roche Ltd.
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Sakura Finetek
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Danaher Corporation
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Hologic, Inc.
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Merck KGaA
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Bio SB
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Becton, Dickinson and Company
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Diapath S.p.A.
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 Appendix

• 11.1 Related Research